1.8100
+0.1200
+(7.10%)
At close: April 11 at 4:00:02 PM EDT
1.8200
+0.01
+(0.55%)
After hours: April 11 at 4:13:37 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Rory Balfour Riggs M.B.A. | Co-Founder & Chairman | 292.31k | -- | 1953 |
| Dr. Peter R. Beetham B.Sc., Ph.D. | Co-Founder, Interim CEO, President, COO & Director | 292.31k | -- | 1963 |
| Dr. Gregory F. Gocal Ph.D. | Co-Founder, Chief Scientific Officer & Executive VP | 266.01k | -- | 1969 |
| Mr. Cornelis Broos M.Sc. | Interim Chief Financial Officer | -- | -- | 1972 |
| Mr. Jason Stokes J.D. | Chief Legal Officer, General Counsel & Corporate Secretary | -- | -- | -- |
| Ms. Rosa Cheuk Kim J.D. | Senior Vice President of Legal | -- | -- | -- |
| Dr. James Radtke Ph.D. | Senior Vice President of Product Development | -- | -- | -- |
| Mr. Tony Moran | Senior Vice President of International Development | -- | -- | -- |
| Ms. Noel Sauer Ph.D. | Senior Vice President of Research | -- | -- | -- |
| Mr. Sean O'Connor Ph.D. | Senior VP and President & CEO of Nucelis | -- | -- | -- |
Cibus, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 157
Description
Cibus, Inc., an agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. It focuses on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or linked to environmental challenges. Cibus, Inc. is headquartered in San Diego, California.
Corporate Governance
Cibus, Inc.’s ISS Governance QualityScore as of April 1, 2025 is 8. The pillar scores are Audit: 8; Board: 9; Shareholder Rights: 2; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 7, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC
Cibus, Inc. Earnings Date
Recent Events
Related Tickers
PVLA Palvella Therapeutics, Inc.
21.76
+9.51%
CSCI COSCIENS Biopharma Inc.
2.8485
+4.72%
VRTX.VI Vertex Pharmaceuticals Incorporated
419.95
+0.70%
OVID Ovid Therapeutics Inc.
0.2800
+9.80%
AURX Nuo Therapeutics, Inc.
1.6000
+1.91%
ONTTF Oxford Nanopore Technologies plc
1.4800
0.00%
KANT Kineta, Inc.
0.2660
0.00%
ZNTL Zentalis Pharmaceuticals, Inc.
1.2300
+8.85%
SRZN Surrozen, Inc.
9.00
0.00%
SYBX Synlogic, Inc.
1.0250
-2.38%